SEC Comment Letter for ACHIEVE LIFE SCIENCES, INC. (ACHV) (CIK 0000949858) (ACHV) — Nov 14, 2019
ACHIEVE LIFE SCIENCES, INC. (ACHV) (CIK 0000949858)
Date: Nov. 14, 2019 · CIK: 0000949858 · Accession: 0000000000-19-015485
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-234530
Letter
November 14, 2019 Richard Stewart Chairman and Chief Executive Officer Achieve Life Sciences, Inc. 1040 West Georgia, Suite 1030, Vancouver, British Columbia, V6E 4H1 Re:Achieve Life Sciences Inc. Registration Statement on Form S-1 Filed November 6, 2019 File No. 333-234530 Dear Mr. Stewart: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Gregory Dundas, Attorney Adviser, at (202) 551-3436 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Chelsea Anderson, Esq.
Show Raw Text
November 14, 2019
Richard Stewart
Chairman and Chief Executive Officer
Achieve Life Sciences, Inc.
1040 West Georgia, Suite 1030,
Vancouver, British Columbia, V6E 4H1
Re:Achieve Life Sciences Inc.
Registration Statement on Form S-1
Filed November 6, 2019
File No. 333-234530
Dear Mr. Stewart:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Gregory Dundas, Attorney Adviser, at (202) 551-3436 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Chelsea Anderson, Esq.